Humanwell Healthcare Group Co Ltd - Asset Resilience Ratio

Latest as of June 2025: 2.75%

Humanwell Healthcare Group Co Ltd (600079) has an Asset Resilience Ratio of 2.75% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Humanwell Healthcare Group Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.03 Billion

≈ $151.35 Million USD Cash + Short-term Investments

Total Assets

CN¥37.56 Billion

≈ $5.50 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Humanwell Healthcare Group Co Ltd's Asset Resilience Ratio has changed over time. See Humanwell Healthcare Group Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Humanwell Healthcare Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Humanwell Healthcare Group Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.03 Billion	2.75%
Total Liquid Assets	CN¥1.03 Billion	2.75%

Asset Resilience Insights

Limited Liquidity: Humanwell Healthcare Group Co Ltd maintains only 2.75% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Humanwell Healthcare Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Humanwell Healthcare Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Humanwell Healthcare Group Co Ltd (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Humanwell Healthcare Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.83%	CN¥1.03 Billion ≈ $151.40 Million	CN¥36.51 Billion ≈ $5.34 Billion	+0.25pp
2023-12-31	2.59%	CN¥935.93 Million ≈ $136.96 Million	CN¥36.20 Billion ≈ $5.30 Billion	-0.04pp
2022-12-31	2.63%	CN¥945.72 Million ≈ $138.39 Million	CN¥36.02 Billion ≈ $5.27 Billion	+1.04pp
2021-12-31	1.59%	CN¥548.09 Million ≈ $80.20 Million	CN¥34.50 Billion ≈ $5.05 Billion	-0.29pp
2020-12-31	1.88%	CN¥593.36 Million ≈ $86.83 Million	CN¥31.63 Billion ≈ $4.63 Billion	+0.18pp
2019-12-31	1.69%	CN¥592.87 Million ≈ $86.76 Million	CN¥35.01 Billion ≈ $5.12 Billion	+1.64pp
2005-12-31	0.05%	CN¥1.00 Million ≈ $146.33K	CN¥2.04 Billion ≈ $299.24 Million	+0.04pp
2004-12-31	0.01%	CN¥95.00K ≈ $13.90K	CN¥1.82 Billion ≈ $267.02 Million	-0.05pp
2003-12-31	0.05%	CN¥897.00K ≈ $131.26K	CN¥1.69 Billion ≈ $246.75 Million	-0.38pp
2002-12-31	0.43%	CN¥6.17 Million ≈ $902.72K	CN¥1.43 Billion ≈ $208.81 Million	+0.43pp
2001-12-31	0.00%	CN¥7.00K ≈ $1.02K	CN¥991.27 Million ≈ $145.05 Million	-0.02pp
2000-12-31	0.02%	CN¥116.00K ≈ $16.97K	CN¥518.12 Million ≈ $75.82 Million	--

pp = percentage points

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.92 Billion

CN¥26.78 Billion CNY

Market Cap Rank

#4249 Global

#701 in China

Share Price

CN¥16.41

Change (1 day)

-1.74%

52-Week Range

CN¥16.41 - CN¥23.03

All Time High

CN¥37.30